Determination of Thiafentanil in Plasma Using Lcâ•Fims

Total Page:16

File Type:pdf, Size:1020Kb

Determination of Thiafentanil in Plasma Using Lcâ•Fims University of Tennessee, Knoxville TRACE: Tennessee Research and Creative Exchange Faculty Publications and Other Works -- Veterinary Medicine -- Faculty Publications and Biomedical and Diagnostic Sciences Other Works 2020 Determination of Thiafentanil in Plasma Using LC–MS Sherry Cox University of Tennessee, Knoxville Joan Bergman University of Tennessee, Knoxville Matthew C. Allender University of Illinois Kimberlee Beckmen Alaska Department of Fish and Game William Lance Wildlife Pharmaceuticals Inc Follow this and additional works at: https://trace.tennessee.edu/utk_compmedpubs Recommended Citation Cox, Sherry; Bergman, Joan; Allender, Matthew C.; Beckmen, Kimberlee; and Lance, William, "Determination of Thiafentanil in Plasma Using LC–MS" (2020). Faculty Publications and Other Works -- Biomedical and Diagnostic Sciences. https://trace.tennessee.edu/utk_compmedpubs/151 This Article is brought to you for free and open access by the Veterinary Medicine -- Faculty Publications and Other Works at TRACE: Tennessee Research and Creative Exchange. It has been accepted for inclusion in Faculty Publications and Other Works -- Biomedical and Diagnostic Sciences by an authorized administrator of TRACE: Tennessee Research and Creative Exchange. For more information, please contact [email protected]. Journal of Chromatographic Science, 2020, Vol. 58, No. 1, 1–4 doi: 10.1093/chromsci/bmz098 Advance Access Publication Date: 9 December 2019 Article Article Determination of Thiafentanil in Plasma Using LC–MS Downloaded from https://academic.oup.com/chromsci/article-abstract/58/1/1/5667452 by guest on 14 April 2020 Sherry Cox1, Joan Bergman1, Matthew C. Allender2, Kimberlee Beckmen3, and William Lance4 1Department of Biomedical and Diagnostic Sciences, College of Veterinary Medicine, University of Tennessee, 2407 River Drive, Knoxville, TN, USA 2Wildlife Epidemiology Laboratory, Department of Veterinary Clinical Medicine, College of Veterinary Medicine, University of Illinois, Urbana IL, USA 3Wildlife Health and Disease Surveillance Program, Division of Wildlife Conservation, Alaska Department of Fish and Game, 1300 College Road, Fairbanks AK, USA 4Wildlife Pharmaceuticals Inc., 1230 West Ash, Windsor, CO, USA Author to whom correspondence should be addressed. Email: [email protected] Abstract A new method of analysis has been developed and validated for the determination of thiafentanil in plasma. After protein precipitation, samples were separated on an XBridge BEH C18 column and quantified using mass spectrometry. The mobile phase was a mixture of water with 0.1% formic acid and acetonitrile with 0.1% formic acid (90:10). The standard curve ranged from 0.1 to 25 ng/mL. Intra- and Inter-assay variability for thiafentanil was less than 10%, and the average recovery was greater than 95%. The lower limit of quantification was 0.1 ng/mL. This is the first validated method for thiafentanil analysis in plasma. Introduction effects after apparent antagonism. Renarcotization is dangerous for free-ranging wildlife because prolonged struggling during recovery Opioid agonists are valuable for immobilization of many nondo- could cause several life-threatening problems, such as hyperthermia mestic species. Opioids such as etorphine and carfentanil are often and trauma (2). The shorter half-life also means that targeted animals preferred for their potency, fast action and ability to have their effects may be handled and secured quicker than with other opioids, prevent- reversed. However, this class of drug is associated with adverse side ing problems with trauma, overheating and escapes by free-ranging effects such as excitement, muscle rigidity, regurgitation, bradypnea, wildlife. abnormal blood pressure, hyperthermia and lactic acidosis (1). A literature search revealed no published methods for the deter- Thiafentanil is a potent opioid that is a synthetic fentanyl deriva- mination of thiafentanil in plasma. Therefore, the aim of this paper tive, structurally similar to sufentanil. It has a morphine-like anal- was to develop a simple, sensitive, specific and reliable method for gesic mode of action and produces rapid immobilization following determining thiafentanil concentrations using protein precipitation intramuscular injection. It is used for immobilization of captive minor and mass-spectrometry detection. species and free-ranging hoof stock and represents the next genera- tion of opioid immobilizing agents. The restraint and immobilization of nondomestic ungulates has been extremely problematic and there Experimental continues to be a need for agents that will immobilize these animals quickly and safely (2). When compared to other opioids, thiafentanil Instrumentation and reagents has a much shorter induction time, by as much as 50%, while The chromatography system consisted of an Acquity Arc system and retaining agonist activity (3). In addition, recovery times after antago- an Acquity QDa single-quadrupole mass detector (Waters, Milford, × nization are also shorter (4). Because it has a shorter half-life, there is MA). Separation occurred on an XBridge BEH C18 column (4.6 less incidence of renarcotization, which is the reoccurrence of opioid 50 mm, 3.5 μm) preceded by a 3.5 μm BEH C18 guard column © The Author(s) 2019. Published by Oxford University Press. All rights reserved. For Permissions, please email: [email protected] 1 2 Cox et al. Method validation The method was validated according to the Guidelines for Bioanalyt- ical Method Validation published by the Food and Drug Administra- tion (5). Validation of the method was carried out using QC samples. All of the QC samples and calibration curves were prepared in a plasma matrix. The validation process looked at accuracy, precision, selectivity, sensitivity, reproducibility and stability. Selectivity Selectivity was determined by injecting blank plasma from six differ- ent deers to confirm no interfering peaks around the retention time of both thiafentanil and fentanyl, the internal standard (IS). Figure 1. Structures of thiafentanil and fentanyl. Downloaded from https://academic.oup.com/chromsci/article-abstract/58/1/1/5667452 by guest on 14 April 2020 Calibration curve, linearity and quality control samples × (3.9 5 mm). The mobile phase was a mixture of (A) 0.1% formic The final concentrations for the calibration standard curve were 0.1, acid in water and (B) 0.1% formic acid in acetonitrile (90:10, v/v). 0.25, 0.5, 1, 2.5, 5, 10 and 25 ng/mL. The calibration curve was The mixture was pumped at a starting ratio of 90% A and 10% B and constructed by using the ratio of the peak area of the analyte divided then changes to 10% A and 90% B over 4 minutes and then returns to by the peak area of the internal standard versus the concentration initial conditions over 3 minutes. The flow rate was 0.6 mL/min and ◦ and obtained on five different days. Linearity was assessed by linear the column temperature was 30 C. The compounds were detected regression analysis and expressed as the coefficient of determination by positive selected ion recording. The scan rate was 5 points/second, (r2). The standard deviations (SD) of the slope, intercepts and regres- gain 10, capillary voltage 0.8 kV,cone voltage for thiafentanil 8, cone ◦ sion coefficient were calculated. The QC samples were prepared in a voltage for fentanyl 15, ion source temperature 150 C and probe ◦ similar manner as the calibration standards at four different levels temperature 600 C. Nitrogen was used as the nebulizing gas and 0.3, 0.75, 3.5 and 17.5 ng/mL. The acceptance criterion for each maintained at 100 psi. Thiafentanil was detected at 417 m/z and back-calculated standard was 15% deviation from the nominal value fentanyl was detected at 337 m/z. except lower limit of quantification (LLOQ), which was set at 20%. Thiafentanil (Figure 1) (Wildlife Pharmaceuticals Inc., Windsor, CO) was 98% pure. Fentanyl (Figure 1), which was the internal standard (99% purity) was purchased from US Pharmacopeia Accuracy, precision and recovery (Rockville, MD). All other mass spectrometry grade chemicals and The precision and accuracy of the assay were determined using QC solvents were purchased from Fisher Scientific (Pittsburg, PA). Water samples of known thiafentanil concentrations (0.3, 0.75, 3.5 and (18.2 megaohm) was obtained from a Barnstead Nanopure Infinity 17.5 ng/mL), which were processed freshly each validation day. Five (Dubuque, IA) ultrapure water system. replicates of each QC were analyzed during the same day and on five different days, and the intra- and inter-assay means, SD and coefficient of variation were calculated. Recoveries were calculated as Preparation of calibration standards the measured concentrations divided by the expected concentrations Five milligrams of thiafentanil or fentanyl were weighed and dis- and expressed as a percentage (5). The tailing factor was calculated = solved in methanol to produce stock concentrations of 100 μg/mL. by As W0.05/2f,whereW0.05 is the width of the peak at 5% height Dilutions of the stock standards were prepared in methanol to and f is the distance from the peak maximum to the leading edge of produce 0.01, 0.1 and 1 μg/mL working stock solutions. Standards the peak height from the baseline (6). were aliquoted into 2 mL vials to prevent cross contamination and ◦ evaporation. All solutions were stored at 4 C. By comparing standard areas over time, it was determined that solutions were stable for a Results minimum of 8 months. Selectivity For preparation of calibration standards and quality control Endogenous components from the plasma did not interfere with the samples, appropriate volumes of stock solutions were placed in 13 elution of the compounds of interest. Six different blank plasmas were × 100 mm glass tubes and evaporated with nitrogen then untreated used in the pre-validation process. Figure 2 shows chromatograms of plasma was added. a (A) blank plasma, (B) a 0.5 ng/mL spiked plasma standard and (C) a plasma sample from a deer 30 minutes after a 0.07 mg/kg dose via nonmetal dart administration. Retention times were 4.32 minutes for Sample preparation thiafentanil and 4.56 minutes for fentanyl.
Recommended publications
  • FOI Summary, Thianil (Thiafentanil Oxalate), MIF 900-000
    Date of Index Listing: June 16, 2016 FREEDOM OF INFORMATION SUMMARY ORIGINAL REQUEST FOR ADDITION TO THE INDEX OF LEGALLY MARKETED UNAPPROVED NEW ANIMAL DRUGS FOR MINOR SPECIES MIF 900-000 THIANIL (thiafentanil oxalate) Captive non-food-producing minor species hoof stock “For immobilization of captive minor species hoof stock excluding any member of a food- producing minor species such as deer, elk, or bison and any minor species animal that may become eligible for consumption by humans or food-producing animals.” Requested by: Wildlife Pharmaceuticals, Inc. Freedom of Information Summary MIF 900-000 TABLE OF CONTENTS I. GENERAL INFORMATION: ............................................................................. 1 II. EFFECTIVENESS AND TARGET ANIMAL SAFETY: .............................................. 1 A. Findings of the Qualified Expert Panel: ...................................................... 2 B. Literature Considered by the Qualified Expert Panel: ................................... 4 III. USER SAFETY: ............................................................................................. 6 IV. AGENCY CONCLUSIONS: .............................................................................. 7 A. Determination of Eligibility for Indexing: .................................................... 7 B. Qualified Expert Panel: ............................................................................ 7 C. Marketing Status: ................................................................................... 7 D. Exclusivity:
    [Show full text]
  • 2020 State of Nebraska Statutes Relating to Pharmacy
    2020 STATE OF NEBRASKA STATUTES RELATING TO PHARMACY PRACTICE ACT Department of Health and Human Services Division of Public Health Licensure Unit 301 Centennial Mall South, Third Floor PO Box 94986 Lincoln, NE 68509-4986 STATUTE INDEX UNIFORM CONTROLLED SUBSTANCES ACT 28-401. Terms, defined. 28-401.01. Act, how cited. 28-401.02. Act; how construed. 28-402. Repealed. Laws 2001, LB 398, § 97. 28-403. Administering secret medicine; penalty. 28-404. Controlled substances; declaration. 28-405. Controlled substances; schedules; enumerated. 28-406. Registration; fees. 28-407. Registration required; exceptions. 28-408. Registration to manufacture or distribute controlled substances; factors considered. 28-409. Registrant; disciplinary action; grounds; procedure. 28-410. Records of registrants; inventory; violation; penalty; storage. 28-411. Controlled substances; records; by whom kept; contents; compound controlled substances; duties. 28-412. Narcotic drugs; administration to narcotic-dependent person; violation; penalty. 28-413. Distribution to another registrant; manner. 28-414. Controlled substance; Schedule II; prescription; contents. 28-414.01. Controlled substance; Schedule III, IV, or V; medical order, required; prescription; contents; pharmacist; authority to adapt prescription; duties. 28-414.02. Prescription created, signed, transmitted, and received electronically; records. 28-414.03. Controlled substances; maintenance of records; label. 28-414.04. Controlled substance; transfer. 28-414.05. Controlled substance; destruction; records. 28-414.06. Controlled substance; practitioner; provide information; limit on liability or penalty. 28-414.07. Controlled substances; chemical analysis; admissible as evidence in preliminary hearing. 28-415. Narcotic drugs; label; requirements. 28-416. Prohibited acts; violations; penalties. 28-417. Unlawful acts; violations; penalty. 28-418. Intentional violations; penalty.
    [Show full text]
  • MISSISSIPPI LEGISLATURE REGULAR SESSION 2020 By
    MISSISSIPPI LEGISLATURE REGULAR SESSION 2020 By: Senator(s) Jordan, Jackson (11th) To: Drug Policy; Judiciary, Division A SENATE BILL NO. 2694 1 AN ACT TO AMEND SECTION 41-29-113, MISSISSIPPI CODE OF 1972, 2 TO ADD FLUALPRAZOLAM, FLUBROMAZEPAM, FLUBROMAZOLAM AND CLONAZOLAM 3 TO SCHEDULE I BECAUSE THESE DRUGS HAVE NO LEGITIMATE MEDICAL USE 4 AND HAVE HIGH POTENCY WITH GREAT POTENTIAL TO CAUSE HARM; TO AMEND 5 SECTION 41-29-115, MISSISSIPPI CODE OF 1972, TO REVISE SCHEDULE II 6 TO CLARIFY THE CHEMICAL NAME OF THIAFENTANIL; TO AMEND SECTION 7 41-29-119, MISSISSIPPI CODE OF 1972, TO ADD TO SCHEDULE IV THE 8 DRUGS BREXANOLONE (ZULRESSO) AND SOLRIAMFETOL (SUNOSI) BECAUSE 9 THESE DRUGS RECENTLY HAVE BEEN APPROVED FOR MEDICAL USE BY THE 10 FEDERAL DRUG ADMINISTRATION; AND FOR RELATED PURPOSES. 11 BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF MISSISSIPPI: 12 SECTION 1. Section 41-29-113, Mississippi Code of 1972, is 13 amended as follows: 14 41-29-113. 15 SCHEDULE I 16 (a) Schedule I consists of the drugs and other substances, 17 by whatever official name, common or usual name, chemical name, or 18 brand name designated, that is listed in this section. 19 (b) Opiates. Unless specifically excepted or unless listed 20 in another schedule, any of the following opiates, including their 21 isomers, esters, ethers, salts and salts of isomers, esters and S. B. No. 2694 *SS08/R210* ~ OFFICIAL ~ G1/2 20/SS08/R210 PAGE 1 (csq\tb) 22 ethers, whenever the existence of these isomers, esters, ethers 23 and salts is possible within the specific chemical designation:
    [Show full text]
  • Laws 2021, LB236, § 4
    LB236 LB236 2021 2021 LEGISLATIVE BILL 236 Approved by the Governor May 26, 2021 Introduced by Brewer, 43; Clements, 2; Erdman, 47; Slama, 1; Lindstrom, 18; Murman, 38; Halloran, 33; Hansen, B., 16; McDonnell, 5; Briese, 41; Lowe, 37; Groene, 42; Sanders, 45; Bostelman, 23; Albrecht, 17; Dorn, 30; Linehan, 39; Friesen, 34; Aguilar, 35; Gragert, 40; Kolterman, 24; Williams, 36; Brandt, 32. A BILL FOR AN ACT relating to law; to amend sections 28-1202 and 69-2436, Reissue Revised Statutes of Nebraska, and sections 28-401 and 28-405, Revised Statutes Cumulative Supplement, 2020; to redefine terms, change drug schedules, and adopt federal drug provisions under the Uniform Controlled Substances Act; to provide an exception to the offense of carrying a concealed weapon as prescribed; to define a term; to change provisions relating to renewal of a permit to carry a concealed handgun; to provide a duty for the Nebraska State Patrol; to eliminate an obsolete provision; to harmonize provisions; and to repeal the original sections. Be it enacted by the people of the State of Nebraska, Section 1. Section 28-401, Revised Statutes Cumulative Supplement, 2020, is amended to read: 28-401 As used in the Uniform Controlled Substances Act, unless the context otherwise requires: (1) Administer means to directly apply a controlled substance by injection, inhalation, ingestion, or any other means to the body of a patient or research subject; (2) Agent means an authorized person who acts on behalf of or at the direction of another person but does not include a common or contract carrier, public warehouse keeper, or employee of a carrier or warehouse keeper; (3) Administration means the Drug Enforcement Administration of the United States Department of Justice; (4) Controlled substance means a drug, biological, substance, or immediate precursor in Schedules I through V of section 28-405.
    [Show full text]
  • Swedish National Threat Assessment on Fentanyl Analogues and Other Synthetic Opioids
    Swedish National Threat Assessment on fentanyl analogues and other synthetic opioids National Operations Department Contents Contents Summary ........................................................................................4 Recommendations ................................................................... 36 Definitions .....................................................................................6 Amendment to the Postal Act concerning the obligation of secrecy ........................................................ 36 Introduction ..................................................................................7 New sections of law ................................................................ 36 Aim ...............................................................................................8 Revision/relaxation of the Swedish Public Access Delimitations................................................................................8 to Information and Secrecy Act, providing the History ............................................................................................9 police with increased possibilities to disclose information to the Social Services concerning Current legislation ................................................................... 10 suspected users ........................................................................ 37 Legal status ................................................................................ 11 Needs ........................................................................................
    [Show full text]
  • Package Insert/Product Information
    DOSE CHART Thianil The following doses are representative of doses used in field trials. (thiafentanil oxalate) Species Dose rate of n Recommended CII THIANIL Total Dose injectable solution In micrograms/kg In milligrams 2 10 mg/mL Moose 10mg total dose 8 For intramuscular injection in captive non-food-producing minor species hoof stock only. 10mg 1 3 CAUTION: Federal (USA) law restricts this drug to use by or on the order of a licensed Impala 80.7 µg/kg ED90 44 Male 2mg total dose 3 veterinarian. Female 1mg total dose 5 3 NOT APPROVED BY FDA – Legally marked as an FDA Indexed Product under MIF African buffalo 17.0 – 37.0µg/kg 9 Field 10mg total dose 3 900 000. Extra label use prohibited. Boma 5 mg total dose 5 3 Note: In order to be legally marketed an animal drug product intended for a minor Eland 37.0 – 110.0µg/kg 8 Male 15mg total dose 3 species must be Approved, Conditionally Approved, or Indexed by the FDA. THIS Female 10mg total dose PRODUCT IS INDEXED. 5 3 Greater kudu 37.0 – 120.0µg/kg 12 Male 15mg total dose 3 Do not use this product without adequate amounts of reversal agent available. Female 8mg total dose 3 It is a violation of Federal Law to use this product in a manner other than as directed in African elephant 9 Male 15mg total dose 3 the labeling. The term “minor species” means animals other than humans that are not Female 12mg total dose 5 major species. “Major species” means cattle, horses, swine, chickens, turkeys, dogs, and 15 – 40mg total dose cats.
    [Show full text]
  • Method for Evaluating Ion Mobility Spectrometers for Trace Detection of Fentanyl and Fentanyl-Related Substances
    Electronic Supplementary Material (ESI) for Analytical Methods. This journal is © The Royal Society of Chemistry 2019 Supporting Information for: Method for Evaluating Ion Mobility Spectrometers for Trace Detection of Fentanyl and Fentanyl-related Substances Jennifer R. Verkouteren, Jeffrey Lawrence, R. Michael Verkouteren, Edward Sisco National Institute of Standards and Technology, Materials Measurement Science Division, Gaithersburg, MD, USA meas meas Table S1. Measured K0 (K0 ) for fentanyl and fentanyl-related compounds for individual instruments used in main work. Additional K0 for calc single instruments from cited references [1-3]. Calculated K0 (K0 ) from polynomial equation described in main work. Compounds sorted according to those reported in Table 1 of main work, followed by additional fentanyl-related compounds found in an internet search and sorted by molecular weight. Additional fentanyl-related substances drawn primarily from Traceable Opioid Material Kits to Improve Laboratory Detection of Synthetic Opioids in the U.S. provided by the Centers for Disease Control and Prevention (CDC) at https://www.cdc.gov/nceh/dls/erb_opioid_kits.html. meas 2 -1 -1 Compound K0 (cm V s ) calc K0 Individual Platforms, this study [1] [2] [3] MW 2 -1 -1 Name Formula (cm V s ) (Da) 1 2 3 4 5 6 7 Fentanyl C22H28N2O 336.47 1.057 1.052 1.052 1.058 1.056 1.059 1.052 1.065 1.050 1.049 1.049 Furanyl fentanyl C24H26N2O2 374.47 0.999 1.003 1.003 1.012 1.006 1.011 1.005 1.021 1.000 1.000 1.000 Acetyl fentanyl C21H26N2O 322.44 1.083 1.081 1.083 1.088
    [Show full text]
  • Fentanyl, Fentanyl Analogs and Novel Synthetic Opioids: a Comprehensive Review
    Neuropharmacology xxx (2017) 1e12 Contents lists available at ScienceDirect Neuropharmacology journal homepage: www.elsevier.com/locate/neuropharm Invited review Fentanyl, fentanyl analogs and novel synthetic opioids: A comprehensive review * Patil Armenian a, , Kathy T. Vo b, Jill Barr-Walker c, Kara L. Lynch d a Department of Emergency Medicine, University of California, San Francisco-Fresno, 155 N Fresno St., Fresno, CA 93701, USA b Department of Emergency Medicine, University of California, San Francisco, California Poison Control System, San Francisco Division, UCSF Box 1369, San Francisco, CA 94143-1369, USA c University of California, San Francisco, 1001 Potrero Avenue, Library, San Francisco, CA 94110, USA d Department of Laboratory Medicine, University of California, San Francisco, 1001 Potrero Avenue, Clinical Chemistry, San Francisco, CA 94110, USA article info abstract Article history: Deaths from opioid use are increasing in the US, with a growing proportion due to synthetic opioids. Received 12 June 2017 Until 2013, sporadic outbreaks of fentanyl and fentanyl analogs contaminating the heroin supply caused Received in revised form some deaths in heroin users. Since then, fentanyl has caused deaths in every state and fentanyl and its 30 September 2017 analogs have completely infiltrated the North American heroin supply. In 2014, the first illicit pills Accepted 12 October 2017 containing fentanyl, fentanyl analogs, and other novel synthetic opioids such as U-47700 were detected. Available online xxx These pills, which look like known opioids or benzodiazepines, have introduced synthetic opioids to more unsuspecting customers. As soon as these drugs are regulated by various countries, new com- Keywords: fi Opioid pounds quickly appear on the market, making detection dif cult and the number of cases likely Synthetic opioids underreported.
    [Show full text]
  • FACT SHEET Acrylfentanyl
    FACT SHEET Acrylfentanyl May 2017 For more information, please contact: Dr. P. Blanckaert Coordinator Belgian Early Warning System Drugs Scientific Institute of Public Health National Focal Point on Drugs Jyliette Wytsmanstraat 14 B-1050 Brussels, Belgium Tel : 02/642 5408 [email protected] Science at the service of Public health, Food chain safety and Environment. The information in this message is exclusively meant for the EWS-network, and was sent to you, as a member of this network, in a confidential way. Therefore the information in this message may not be copied, transferred or made public without the prior permission of the WIV-ISP. The WIV-ISP takes responsibility for the editing of a press release, if considered as necessary in the framework of its mission. The information contained in this document is also available on the BEWSD-website (with corresponding pdf-files and analytical data). This part of the website is not accessible for the general public. A login can be requested by contacting [email protected]. © Scientific Institute of Public Health, Brussels 2011 This report may not be reproduced, published or distributed without the consent of the ISP | WIV. A. General information Recent sample in Belgium In the first half of May 2017, a death was reported in Belgium after the use of acrylfentanyl. The victim, male, presumably consumed a powder containing acrylfentanyl by sniffing, and was found dead at the scene, in the region of Ghent. It remains unclear whether the victim knowingly consumed acrylfentanyl. Several other powders and tablets were found at the scene, one of which was identified as N- ethylhexedrone, a cathinone of the stimulant category.
    [Show full text]
  • Chapter 124 Controlled Substances
    1 CONTROLLED SUBSTANCES, Ch 124 CHAPTER 124 CONTROLLED SUBSTANCES Referred to in §124B.2, 124C.1, 124E.12, 124E.16, 155A.3, 155A.6, 155A.6A, 155A.6B, 155A.12, 155A.13A, 155A.13C, 155A.17, 155A.17A, 155A.23, 155A.26, 155A.27, 155A.42, 189.16, 204.7, 204.8, 204.14, 204.15, 205.3, 205.11, 205.12, 205.13, 232.45, 232.52, 321.19, 321.215, 422.72, 462A.2, 702.6, 809A.21, 811.1, 811.2, 901.5, 914.7 See §205.11 – 205.13 for additional provisions relating to administration and enforcement This chapter not enacted as a part of this title; transferred from chapter 204 in Code 1993 SUBCHAPTER I 124.302 Registration requirements. 124.303 Registration. DEFINITIONS — CONTROLLED SUBSTANCES ADMINISTRATION — IMITATION CONTROLLED 124.304 Revocation, suspension, or SUBSTANCES restriction of registration. 124.305 Contested case proceedings. 124.101 Definitions. 124.306 Records of registrants. 124.101A Administration of controlled 124.307 Order forms. substances — delegation. 124.308 Prescriptions. 124.101B Factors indicating an imitation controlled substance. SUBCHAPTER IV OFFENSES AND PENALTIES SUBCHAPTER II STANDARDS AND SCHEDULES 124.401 Prohibited acts — manufacture, delivery, possession — 124.201 Duty to recommend changes counterfeit substances, in schedules — temporary simulated controlled amendments to schedules. substances, imitation 124.201A Cannabis-derived products — controlled substances — rules. penalties. 124.202 Controlled substances — listed 124.401A Enhanced penalty for regardless of name. manufacture or distribution 124.203 Substances listed in schedule I — to persons on certain real criteria. property. 124.204 Schedule I — substances 124.401B Possession of controlled included.
    [Show full text]
  • Controlled Substances List (Adopted by Alabama State Board of Health on January 20, 2021, Effective January 20, 2021)
    1 Controlled Substances List (Adopted by Alabama State Board of Health on January 20, 2021, effective January 20, 2021) Schedule I (a) Schedule I shall consist of the drugs and other substances, by whatever official name, common or usual name, or brand name designated, listed in this section. Each drug or substance has been assigned the DEA Controlled Substances Code Number set forth opposite it. (b) Opiates. Unless specifically excepted or unless listed in another schedule, any of the following opiates, including their isomers, esters, ethers, salts, and salts of isomers, esters and ethers, whenever the existence of such isomers, esters, ethers and salts is possible within the specific chemical designation (for purposes of 3-methylthiofentanyl only, the term isomer includes the optical and geometric isomers): (1) Acetyl-alpha-methylfentanyl (N-[1-[1-methyl-2-phenethyl]-4-piperidinyl]- N-phenylacetamide -------------------------------------------------------------------- 9815 (Federal Control Nov. 29, 1985; State Dec. 29, 1985) (2) Acetylmethadol ------------------------------------------------------------------------- 9601 (3) AH-7921 (3,4-dichloro-N-[(1-dimethylamino)cyclohexylmethyl] benzamide -------------------------------------------------------------------------------- 9551 Federal Control May 16, 2016; State June 15, 2016 (4) Allylprodine ----------------------------------------------------------------------------- 9602 (5) Alphacetylmethadol --------------------------------------------------------------------- 9603 (6) Alphameprodine
    [Show full text]
  • Fentanils and Synthetic Cannabinoids: Driving Greater Complexity Into the Drug Situation
    Fentanils and synthetic cannabinoids: driving greater complexity into the drug situation An update from the EU Early Warning System June 2018 Bookmarks Introduction Overview of seizures, 2016-17 Seizures reported by law enforcement during 2016 Synthetic cathinones New benzodiazepines Other substances Synthetic opioids Fentanils: background Situation in Europe Synthetic cannabinoids Background Situation in Europe New challenges, new responses Strengthening early warning and response Discussion and conclusion Acknowledgements References Front cover photos 1. ‘Ching’ typically sold as a ‘legal’ replacement to cocaine. In this case the product contained methoxyacetylfentanyl. Credit: Slovenian National Forensic Laboratory (Police). 2. Plant material from a ‘Spice’ product that contained CP-47,497 C8 homolog. Credit: Slovenian National Forensic Laboratory (Police). 3. Package containing CUMYL-4CN-BINACA powder that shipped from China. Credit: Slovenian National Forensic Laboratory (Police). 4. Fake Xanax tablets that contained cyclopropylfentanyl. Credit: WR Brede, H-M Krabseth and co-workers, St. Olav University Hospital, Trondheim, Norway. Fentanils and synthetic cannabinoids: driving greater complexity into the drug situation An update from the EU Early Warning System June 2018 I Legal notice This publication of the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is protected by copyright. The EMCDDA accepts no responsibility or liability for any consequences arising from the use of the data contained in this document. The contents of this publication do not necessarily reflect the official opinions of the EMCDDA’s partners, any EU Member State or any agency or institution of the European Union. Luxembourg: Publications Office of the European Union, 2018 © European Monitoring Centre for Drugs and Drug Addiction, 2018 Reproduction is authorised provided the source is acknowledged.
    [Show full text]